Efficacy of a Coronary Sinus Reducer for the Treatment of Refractory Angina
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial
Lancet 2024 Apr 04;[EPub Ahead of Print], MJ Foley, CA Rajkumar, F Ahmed-Jushuf, FA Simader, S Chotai, RH Pathimagaraj, M Mohsin, A Salih, D Wang, P Dixit, JR Davies, TR Keeble, C Cosgrove, JC Spratt, PD O'Kane, R De Silva, JM Hill, SS Nijjer, S Sen, R Petraco, GW Mikhail, R Khamis, T Kotecha, FE Harrell, P Kellman, DP Francis, JP Howard, GD Cole, MJ Shun-Shin, RK Al-LameeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.